230 related articles for article (PubMed ID: 8735789)
1. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
Goldsmith JC
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S3-6. PubMed ID: 8735789
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of factor VIII for surgery and major bleeding.
Hay CR; Doughty HI; Savidge GF
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
[TBL] [Abstract][Full Text] [Related]
3. Family issues in continuous infusion therapy with factor VIII.
Manco-Johnson MJ
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S21-5. PubMed ID: 8735793
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
Morfini M; Messori A; Longo G
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S11-4. PubMed ID: 8735791
[TBL] [Abstract][Full Text] [Related]
5. Stability of ADVATE, Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method, during simulated continuous infusion.
Fernandez M; Yu T; Bjornson E; Luu H; Spotts G
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):165-71. PubMed ID: 16575253
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis and continuous infusion for hemophilia: can we afford it?
Aledort LM; Bohn RL
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S35-7. PubMed ID: 8735795
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.
Schulman S; Varon D; Keller N; Gitel S; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):403-7. PubMed ID: 7855792
[TBL] [Abstract][Full Text] [Related]
8. In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion.
DiMichele DM; Lasak ME; Miller CH
Am J Hematol; 1996 Feb; 51(2):99-103. PubMed ID: 8579073
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.
Schwartz RS; Abildgaard CF; Aledort LM; Arkin S; Bloom AL; Brackmann HH; Brettler DB; Fukui H; Hilgartner MW; Inwood MJ
N Engl J Med; 1990 Dec; 323(26):1800-5. PubMed ID: 2123300
[TBL] [Abstract][Full Text] [Related]
10. Design and assessment of clinical trials on continuous infusion.
Schulman S; Martinowitz U
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S7-9. PubMed ID: 8735790
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
[TBL] [Abstract][Full Text] [Related]
12. [Substitutive treatment of hemopjolia A using a new factor VIII concentrate].
Allain JP; Steinbuch M; Meunier L; Muller JY; Soulier JP
Nouv Presse Med; 1976 Apr; 5(16):1047-50. PubMed ID: 1272773
[TBL] [Abstract][Full Text] [Related]
13. Review of pumps for continuous infusion of coagulation factor concentrates: what are the options?
Martinowitz U; Schulman S
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S27-33. PubMed ID: 8735794
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract].
Brühl P; Weibbach L; Brackmann HH
MMW Munch Med Wochenschr; 1975 Mar; 117(10):401-4. PubMed ID: 804604
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of coagulation factor products.
Stachnik JM; Gabay MP
Ann Pharmacother; 2002 May; 36(5):882-91. PubMed ID: 11978168
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
Duckert F; Müller G; Meili EO
Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
[No Abstract] [Full Text] [Related]
17. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
18. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
Bona RD; Weinstein RA; Weisman SJ; Bartolomeo A; Rickles FR
Am J Hematol; 1989 Sep; 32(1):8-13. PubMed ID: 2502914
[TBL] [Abstract][Full Text] [Related]
19. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
20. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
Brackmann HH; Gormsen J
Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
